chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Fibrin D dimer, Hypercoagulation, Hypertension, Hypothyroidism, Leukopenia
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary:   Patient is a 74 y.o. female patient who is being discharged today.   Hospital Course:    Acute on chronic respiratory failure due to COVID-19 pneumonia  Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema  Dexamethasone 6 milligram X 10 days  Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n.  Nasal cannula 3 liters    AKI on chronic kidney disease  Cr improving 25/1.41  Bicarb 20  BMP daily a.m.    Hyponatremia 139    Hypothyroidism Levothyroxine 125 micrograms daily    Arterial hypertension  Toprol 12.5 milligram p.o. daily    History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema    Leukopenia - Resolved    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Metabolic function test, Renal impairment, SARS-CoV-2 test positive, Scan myocardial perfusion abnormal, Vaccine breakthrough infection
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary:   Patient is a 74 y.o. female patient who is being discharged today.   Hospital Course:    Acute on chronic respiratory failure due to COVID-19 pneumonia  Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema  Dexamethasone 6 milligram X 10 days  Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n.  Nasal cannula 3 liters    AKI on chronic kidney disease  Cr improving 25/1.41  Bicarb 20  BMP daily a.m.    Hyponatremia 139    Hypothyroidism Levothyroxine 125 micrograms daily    Arterial hypertension  Toprol 12.5 milligram p.o. daily    History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema    Leukopenia - Resolved    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Chills, Erythema, Fatigue, Pain in extremity
Clinical narrative: shivers stomach ache extreme fatigue very sore arm and redness
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Expired vaccine was administerd due to misunderstanding when establishing expiration dateon database report
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Condition aggravated, Dyspnoea, Heart rate increased
Clinical narrative: Full body aches, swollen right armpit, naseau, vomiting, restlessness, inability to sleep, chills, presumed fever, increased resting heart rate (up by 40+ bpm compared to normal), shortness of breath, anxiety
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Oedema peripheral, Pain, Pyrexia
Clinical narrative: Full body aches, swollen right armpit, naseau, vomiting, restlessness, inability to sleep, chills, presumed fever, increased resting heart rate (up by 40+ bpm compared to normal), shortness of breath, anxiety
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness, Vomiting
Clinical narrative: Full body aches, swollen right armpit, naseau, vomiting, restlessness, inability to sleep, chills, presumed fever, increased resting heart rate (up by 40+ bpm compared to normal), shortness of breath, anxiety
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Chest pain, Dizziness, Dyspnoea, Heart rate increased
Clinical narrative: lient reported that within 3 minutes of receiving the first dose of Pfizer COVID vaccine, she developed chest pain, throat swelling, and sweating. The client also stated her heart rate and blood pressure increased. Client stated that emergency medical services presented and evaluated the client, but stated that no medications were administered. The client states she declined transport. The client stated the chest pain, fever, and difficulty breathing lasted 3 weeks and that the throat swelling lasted 3 days. The client did report dizziness after receiving the first dose of Pfizer COVID vaccine and has not eaten today. The client did also report feeling shortness of breath after receiving the first dose. After receiving the first dose Pfizer COVID vaccine, the client stated she was taking over the counter AllerClear (loratadine) for ?sinus issues? which provided some relief. The client didn't follow up with her PCP or allergist regarding her symptoms. The client reported a history of spinal fusion surgery 3 years ago. The client denies any current medications or known allergies.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pharyngeal swelling, Pyrexia
Clinical narrative: lient reported that within 3 minutes of receiving the first dose of Pfizer COVID vaccine, she developed chest pain, throat swelling, and sweating. The client also stated her heart rate and blood pressure increased. Client stated that emergency medical services presented and evaluated the client, but stated that no medications were administered. The client states she declined transport. The client stated the chest pain, fever, and difficulty breathing lasted 3 weeks and that the throat swelling lasted 3 days. The client did report dizziness after receiving the first dose of Pfizer COVID vaccine and has not eaten today. The client did also report feeling shortness of breath after receiving the first dose. After receiving the first dose Pfizer COVID vaccine, the client stated she was taking over the counter AllerClear (loratadine) for ?sinus issues? which provided some relief. The client didn't follow up with her PCP or allergist regarding her symptoms. The client reported a history of spinal fusion surgery 3 years ago. The client denies any current medications or known allergies.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Very noticeable tinnitus began 2 days after receiving the vaccination.  Volume is about 4 out of 10, has remained constant ever since.  Ringing with some whooshing, no pulsing, no detrimental effect on perception of music or speech.  Tinnitus became more severe 2 days after receiving a Moderna booster in late November 2021.  I will file a separate VAERS report for the booster shot.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site hypoaesthesia
Clinical narrative: CUSTOMER REPORTS NUMBNESS AT INJECTION SITE EXTENDING TO HER FINGER TIPS
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Adult failure to thrive, Anticoagulant therapy, Atrial fibrillation, Bifascicular block
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 03/13/2021. Patient was hospitalized from 12/28/2021 - 12/30/2021. Below is copied from discharge summary:   The patient is a 83 y.o. male patient who is being discharged today.   Hospital Course:    AKI on CKD  Likely 2/2 decreased fluid intake Creatinine  1.1 at baseline  Received IVF  Renally dose medications  Avoid nephrotoxic agents    Failure to thrive  - tolerating PO diet well COVID-19  FTT likely 2/2 COVID-19  PT/OT: back to STR Pt not requiring oxygen  Supportive care with Tylenol for fevers, DuoNebs p.r.n., and dextromethorphan/guaifensin    Elevated troponin  Troponin elevation in the setting of COVID-19 ECG showing bifascicular block, seen on previous ECGs  No change in delta  No chest pain, likely due to AKI   Hypermagnesemia  Mild, monitor    Normocytic anemia  Stable, monitor    Paroxysmal atrial fibrillation  ECG showing bifascicular block  Rate controlled  Cont Eliquis    COPD No exacerbation  Duonebs prn     Hypertension  Resume losartan   Dementia At baseline  Cont Aricept and Memantine    Gastroesophageal reflux disease Home medication non formulary, cont with Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine normal, COVID-19, Chronic kidney disease, Condition aggravated, Electrocardiogram abnormal
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 03/13/2021. Patient was hospitalized from 12/28/2021 - 12/30/2021. Below is copied from discharge summary:   The patient is a 83 y.o. male patient who is being discharged today.   Hospital Course:    AKI on CKD  Likely 2/2 decreased fluid intake Creatinine  1.1 at baseline  Received IVF  Renally dose medications  Avoid nephrotoxic agents    Failure to thrive  - tolerating PO diet well COVID-19  FTT likely 2/2 COVID-19  PT/OT: back to STR Pt not requiring oxygen  Supportive care with Tylenol for fevers, DuoNebs p.r.n., and dextromethorphan/guaifensin    Elevated troponin  Troponin elevation in the setting of COVID-19 ECG showing bifascicular block, seen on previous ECGs  No change in delta  No chest pain, likely due to AKI   Hypermagnesemia  Mild, monitor    Normocytic anemia  Stable, monitor    Paroxysmal atrial fibrillation  ECG showing bifascicular block  Rate controlled  Cont Eliquis    COPD No exacerbation  Duonebs prn     Hypertension  Resume losartan   Dementia At baseline  Cont Aricept and Memantine    Gastroesophageal reflux disease Home medication non formulary, cont with Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fluid intake reduced, Hypermagnesaemia, Normocytic anaemia, Nucleic acid test, Pyrexia
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 03/13/2021. Patient was hospitalized from 12/28/2021 - 12/30/2021. Below is copied from discharge summary:   The patient is a 83 y.o. male patient who is being discharged today.   Hospital Course:    AKI on CKD  Likely 2/2 decreased fluid intake Creatinine  1.1 at baseline  Received IVF  Renally dose medications  Avoid nephrotoxic agents    Failure to thrive  - tolerating PO diet well COVID-19  FTT likely 2/2 COVID-19  PT/OT: back to STR Pt not requiring oxygen  Supportive care with Tylenol for fevers, DuoNebs p.r.n., and dextromethorphan/guaifensin    Elevated troponin  Troponin elevation in the setting of COVID-19 ECG showing bifascicular block, seen on previous ECGs  No change in delta  No chest pain, likely due to AKI   Hypermagnesemia  Mild, monitor    Normocytic anemia  Stable, monitor    Paroxysmal atrial fibrillation  ECG showing bifascicular block  Rate controlled  Cont Eliquis    COPD No exacerbation  Duonebs prn     Hypertension  Resume losartan   Dementia At baseline  Cont Aricept and Memantine    Gastroesophageal reflux disease Home medication non formulary, cont with Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased, Vaccine breakthrough infection
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 03/13/2021. Patient was hospitalized from 12/28/2021 - 12/30/2021. Below is copied from discharge summary:   The patient is a 83 y.o. male patient who is being discharged today.   Hospital Course:    AKI on CKD  Likely 2/2 decreased fluid intake Creatinine  1.1 at baseline  Received IVF  Renally dose medications  Avoid nephrotoxic agents    Failure to thrive  - tolerating PO diet well COVID-19  FTT likely 2/2 COVID-19  PT/OT: back to STR Pt not requiring oxygen  Supportive care with Tylenol for fevers, DuoNebs p.r.n., and dextromethorphan/guaifensin    Elevated troponin  Troponin elevation in the setting of COVID-19 ECG showing bifascicular block, seen on previous ECGs  No change in delta  No chest pain, likely due to AKI   Hypermagnesemia  Mild, monitor    Normocytic anemia  Stable, monitor    Paroxysmal atrial fibrillation  ECG showing bifascicular block  Rate controlled  Cont Eliquis    COPD No exacerbation  Duonebs prn     Hypertension  Resume losartan   Dementia At baseline  Cont Aricept and Memantine    Gastroesophageal reflux disease Home medication non formulary, cont with Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Adverse event, Exercise tolerance decreased, Fatigue
Clinical narrative: Beginning within 24hrs past second dose on 10/14/21, severe physical exhaustion that improved roughly 72 hours later. Post 72 hours dramatic decline in physical performance that has persisted through current date, 02/2022. Pre-vaccine, long distance runner comfortably running 20+ miles at once. Post- vaccine, struggle to run 5+ miles. Have run 10+ miles once since vaccine and experienced exhaustion early in the activity that remained throughout. Performance stats demonstrate slower speeds and working harder. Reporting as an adverse event here because it has felt like a continuation of the immediate post- vaccine exhaustion that I've been waiting to improve. Nothing I've done has seemed to improve it.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Erythema, Heart rate increased, Lip swelling, Pharyngeal swelling
Clinical narrative: Swelling of lips and throat, bright red face, heartbeat  and blood pressure increase
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Angiogram retina, Angiotensin converting enzyme, Antineutrophil cytoplasmic antibody negative, Antinuclear antibody negative
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Antiphospholipid antibodies negative, Blood homocysteine normal, C-reactive protein normal, Cardiac monitoring normal, Cardiovascular evaluation
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulation test normal, Cytogenetic analysis, Echocardiogram abnormal, Ejection fraction normal, Electrophoresis protein normal
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count normal, Glycosylated haemoglobin normal, HIV test negative, Headache, Immunology test normal
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammatory marker test, Laboratory test normal, Lipids normal, Macular oedema, Magnetic resonance imaging
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test normal, Mitral valve thickening, Mycobacterium tuberculosis complex test, Ophthalmological examination abnormal, Optical coherence tomography abnormal
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Protein C, Prothrombin time normal, Red blood cell sedimentation rate normal, Retinal ischaemia, Retinal vein occlusion
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid factor, Sinus rhythm, Treponema test negative, Tricuspid valve incompetence, Ultrasound Doppler
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Visual impairment
Clinical narrative: This is a previously healthy 40 year old female that  patient began having visual disturbances and a severe headache 1 week following her initial dose of the vaccine. Her symptoms progressed and she was evaluated by a retinal specialist 2 -3 weeks later. Examination showed a central retinal vein occlusion in her left eye. She had an OCT, fluorescein angiogram and fundus photos which revealed macular edema and ischemic peripheral retina.  She has needed to have intravitreal injections of aflibercept to control her macular edema and she is being monitored for neovascular complications.  She has had an extensive  systemic workup  which could not identify an underling cause.    This  included a negative hypercoagulable work-up with oncology and a negative autoimmune/inflammatory work-up.  She had an extensive cardiovascular work-up including a negative Zio patch, Echocardiogram with shunt study, and carotid ultrasound.      Infiltrative causes were  been ruled out with an MRI.  It is my impression as a retina surgeon that her retinal vein occlusion was a result of her vaccine given the temporal association and reports of prothrombotic events happening after these vaccines.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: This was a booster dose of Moderna after receiving the J&J vaccine in March 2021.  2 days after receiving the J&J vaccine in March I'd had a sudden onset of tinnitus that remained at a constant 4/10 volume afterward.  I filed a separate VAERS report about that first incident.  2 days after receiving the Moderna booster in late November I had a sudden increase in the tinnitus effect (ringing with some whooshing, no pulsing, no negative effect on the sound of music or speech), nearly doubling it to about a 7/10 volume.  Over the next few weeks the strength of the effect varied from day to day, at some points going as high as 8/10 volume and at others going down to as low as 2/10 or 3/10 volume, but this eventually stabilized to a constant 6/10 volume and has remained there ever since.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: Severe itching and non-localized rash and hives, ranging in locale from the top of the head to the neck, chest, waist, groin, legs and feet.  They would often manifest in the form of "slashes" (as if scratched deeply) and often quite "geometric" in nature (imagine pulling tape off the body and leaving a 6" long and 1/4" wide red mark).  It has been CRUCIAL to have a STRONG discipline to not scratch because during an event any contact with the site(s), including via clothes, would greatly compound effect.  The presentation of symptoms was predictably FAR worse after a shower, particularly late at night.  Nighttime generally also seems to correlate with more events.  The locale of any particular rash/itch would last 30-60 minutes.  Those on the head would almost become oddly painful.   Severity was quite consistent for the first 2 weeks, then SLIGHTLY less the next 2 weeks, with a noticeable improvement in week 5.  I'm 99% certain that the Moderna Booster received on 12/21 was the ONLY cause for this.  I've NEVER been allergic to anything, and I had NO changes in behavior or diet or clothes or anything in my lifestyle in the 2 weeks preceding onset (12/29).  Topical creams (e.g., Hyrdocortisone) would SEEMS to help briefly, but not much.  A round of oral steroids (Prednisone, prescribed by an Urgent Care facility) taken Jan 2-8 did nothing at all to help.   Now, 6 weeks later, I feel 90% better, still with some random events (again, mostly at night).
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lymphadenopathy, Pain
Clinical narrative: right area erythema, and pain, pt has some axillary swelling
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: RN noted that after administration of the vaccine, while the needle was being removed from the client's arm, the client moved her body. RN noted the needle grazed the client's skin over the client's left deltoid area after removal from the client's arm.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Pain in extremity
Clinical narrative: Continuous throbbing ache - now numbness in my entire arm plus the pain.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Lip swelling, Swelling face, Swollen tongue
Clinical narrative: swollen lips, face, underneath tongue, knees
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring, Dizziness, Dyspnoea, Palpitations
Clinical narrative: I have been having heart palpitations, dizziness and shortness of breath. I am currently wearing a ZIO patch to monitor the palpitations.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Dizziness, Headache, Hyperhidrosis, Musculoskeletal stiffness
Clinical narrative: Severe pain, dizzy, nausea upon administration. By 8pm, shaking, pain in back, chest. Couldn't unclench my fist. Severe headache, mTachycardia, low grade fever. Day two continue with pain, woke up that night with my night shirt soaked with sweat. Never had this before.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pain, Pyrexia, Tachycardia, Tremor
Clinical narrative: Severe pain, dizzy, nausea upon administration. By 8pm, shaking, pain in back, chest. Couldn't unclench my fist. Severe headache, mTachycardia, low grade fever. Day two continue with pain, woke up that night with my night shirt soaked with sweat. Never had this before.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Differential white blood cell count, Dizziness, Electrocardiogram, Full blood count
Clinical narrative: Dizziness - Day 1 Dizziness, nausea, vomiting - Day 2 and Day 3  0.9% sodium chloride Ondansetron (ZOFRAN) Meclizine (ANTIVERT)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Nausea, Vomiting
Clinical narrative: Dizziness - Day 1 Dizziness, nausea, vomiting - Day 2 and Day 3  0.9% sodium chloride Ondansetron (ZOFRAN) Meclizine (ANTIVERT)
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia, Syncope
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Fever-Medium, Systemic: Visual Changes/Disturbances-Medium
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli, Visual impairment
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Fever-Medium, Systemic: Visual Changes/Disturbances-Medium
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anion gap, Blood glucose normal, Chest X-ray normal, Chest discomfort, Contusion
Clinical narrative: The evening of receiving the covid vaccine, patient experienced bruising to upper and lateral thigh with mild tenderness.  The lower extremity initially became swollen, then resolved.  Skin of feet began to peel off.  She also experienced mild intermittent chest tightness.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Full blood count, Haematocrit increased, Haemoglobin increased, Metabolic function test
Clinical narrative: The evening of receiving the covid vaccine, patient experienced bruising to upper and lateral thigh with mild tenderness.  The lower extremity initially became swollen, then resolved.  Skin of feet began to peel off.  She also experienced mild intermittent chest tightness.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Protein total normal, Red blood cell count increased, Red blood cell sedimentation rate increased, Skin exfoliation
Clinical narrative: The evening of receiving the covid vaccine, patient experienced bruising to upper and lateral thigh with mild tenderness.  The lower extremity initially became swollen, then resolved.  Skin of feet began to peel off.  She also experienced mild intermittent chest tightness.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Ultrasound Doppler
Clinical narrative: The evening of receiving the covid vaccine, patient experienced bruising to upper and lateral thigh with mild tenderness.  The lower extremity initially became swollen, then resolved.  Skin of feet began to peel off.  She also experienced mild intermittent chest tightness.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Dizziness, Hyperhidrosis, Injection site pain
Clinical narrative: Nauseous, chills, swearing, dizziness, weakness, pain and throbbing at injection site.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea
Clinical narrative: Nauseous, chills, swearing, dizziness, weakness, pain and throbbing at injection site.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Palpitations
Clinical narrative: Heart palpitations in the past 2-ish months, pain recently spread left towards shoulder
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Skin warm, Urticaria
Clinical narrative: Large raised hive that is warm to the touch
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hyperacusis, Hypersomnia, Nausea, Photophobia
Clinical narrative: Was very tired the next day and took a 2 hour nap around 2 pm, feeling better after waking. Vertigo started the following afternoon and by the 24 hour mark was totally incapacitating.  I couldn't stand any noise or light and became overwhelmingly  nauseous with vomiting occurring around 8 pm.  After sleeping for an hour the nausea was gone but the vertigo remained to the point where I needed assistance to safely get to the bathroom.  By about 11 pm the vertigo subsided significantly and I was able to walk unaided again. I slept for 11 hours and today (Feb 13, 2022) I'm only feeling somewhat tired.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Was very tired the next day and took a 2 hour nap around 2 pm, feeling better after waking. Vertigo started the following afternoon and by the 24 hour mark was totally incapacitating.  I couldn't stand any noise or light and became overwhelmingly  nauseous with vomiting occurring around 8 pm.  After sleeping for an hour the nausea was gone but the vertigo remained to the point where I needed assistance to safely get to the bathroom.  By about 11 pm the vertigo subsided significantly and I was able to walk unaided again. I slept for 11 hours and today (Feb 13, 2022) I'm only feeling somewhat tired.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injected limb mobility decreased, Injection site pain
Clinical narrative: I had a really bad reaction to shot number 2 that I did not report. On this booster shot I felt fatigued about 8 hours after the shot. I could barely lift my left arm. I started to develop a bad headache that evening.  The following morning when I woke up at 0730 I had a severe headache and pain in all my joints. I was barely able to lift myself up or move due to the pain and fatigue. I took anti inflammatory and rested. About mid afternoon the next day I noticed under my  left collarbone I had a large swollen lump. I still felt very fatigued. Headache went away, but the next morning today I noticed that in addition to the lump under my left collarbone my entire left armpit is swollen. The injection site is sore and hot to the touch.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Lymphadenopathy, Pain
Clinical narrative: I had a really bad reaction to shot number 2 that I did not report. On this booster shot I felt fatigued about 8 hours after the shot. I could barely lift my left arm. I started to develop a bad headache that evening.  The following morning when I woke up at 0730 I had a severe headache and pain in all my joints. I was barely able to lift myself up or move due to the pain and fatigue. I took anti inflammatory and rested. About mid afternoon the next day I noticed under my  left collarbone I had a large swollen lump. I still felt very fatigued. Headache went away, but the next morning today I noticed that in addition to the lump under my left collarbone my entire left armpit is swollen. The injection site is sore and hot to the touch.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Choking, Cough, Migraine
Clinical narrative: I was getting better from having a cold. At the time of my booster shot, I had a cough and migrane only. After taking the booster shot, I've been coughing constantly. Sometimes it'll be a light cough. Sometimes my cough would be a constant choking like cough. It's been a month and a half and I'm still coughing.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Lethargy, Neck pain, Pain
Clinical narrative: Headache neck headache body aches low grade fever shakes chills lethargic sleepy very sore site interaction
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia, Somnolence, Tremor
Clinical narrative: Headache neck headache body aches low grade fever shakes chills lethargic sleepy very sore site interaction
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine is administered due to minunderstading when  establishing the expiration date in the database report
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: When going to update database it was noted that the resident named had already received 2 doses of Pfizer earlier in the year of 2021.  Family POA stated to facility that resident did not received any of the vaccines until given in 12/21.  Family informed facility that they would look into her last stay facility to see if it was given while in another facility.  Family failed to provide the information of the vaccines given and even though database has it reported that she received the vaccine the family insisted that she receive the 2nd dose on 2/10/22.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymph node pain, Lymphadenopathy
Clinical narrative: Pain in left armpit about 12 hours after vaccination. Felt swollen and tender. About 2 weeks after vaccination all another vaccination symptoms were gone but still felt slight discomfort in arm pit.  Symptom continued and started to become more annoying/noticeable as it never went away. It has been 3 months since vaccination and issue still persists.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Infection, Peripheral swelling
Clinical narrative: Blood infection. Same as after first two shots. Red, swollen hand and forearm.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Intracardiac thrombus, Myocardial infarction, Pain in extremity
Clinical narrative: HEART ATTACK CAUSE BY A BLOOD CLOT SHORTNESS OF BREATH, CHEST PAINS, LEFT ARM PAIN I'M STILL HAVING CHEST PAINS AND STILL SEEING A CARDIOLOGIST A STINT WAS INSERTED
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Stent placement
Clinical narrative: HEART ATTACK CAUSE BY A BLOOD CLOT SHORTNESS OF BREATH, CHEST PAINS, LEFT ARM PAIN I'M STILL HAVING CHEST PAINS AND STILL SEEING A CARDIOLOGIST A STINT WAS INSERTED
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Condition aggravated, Cough, Dizziness, Dyspnoea
Clinical narrative: Client reported that about 5 minutes after receiving the first dose of Moderna COVID vaccine, he experienced and ?anxiety attack.? The client stated ?I felt like I couldn't breathe and like I was going to faint. Also, I was coughing to get air.? The client reported the symptoms lasted one hour and resolved after ?talking with my friends.? The client did not alert staff on site of his symptoms at the time. The client denied any dizziness. The client reported that no medications administered on site or at home. The client didn't follow up with his primary care physician. The client stated he did follow up with psychologist who stated, ?it was my mind tricking me.? The client reported a history of anxiety and is prescribed medications but hasn't taken them in 6 months. The client reported a history of experiencing anxiety attacks with feeling ?worry.? The client stated all the symptoms he experienced after the first Moderna COVID vaccine were normal for his anxiety attacks. The client denied development of any rash, pain in chest, or swelling of throat or tongue after the first dose Moderna COVID vaccine.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Polymyalgia rheumatica, Spinal X-ray
Clinical narrative: Brought on severe symptoms of PMR
Age: 50.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Blood test, Dysstasia, Hepatic enzyme increased, Hypertension
Clinical narrative: I did not have an acute response - response was gradual and progressive.  The month following my last vaccine, I noticed having trouble lifting things (bilateral elbow pain) and difficulty going from a sitting to standing position. Felt as if I had gone through a gluteal workout. Symptoms persisted, so I notified my PCP.
Age: 50.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Laboratory test, Sacroiliitis, Ultrasound liver
Clinical narrative: I did not have an acute response - response was gradual and progressive.  The month following my last vaccine, I noticed having trouble lifting things (bilateral elbow pain) and difficulty going from a sitting to standing position. Felt as if I had gone through a gluteal workout. Symptoms persisted, so I notified my PCP.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Magnetic resonance imaging, Mental disorder, Speech disorder
Clinical narrative: lost 50 pounds, dizzines, mental and speaking problems
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: lost 50 pounds, dizzines, mental and speaking problems
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: PARESTHESIA IN FEET, LEGS, AND ARMS
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Electrocardiogram, Pain in jaw, X-ray limb
Clinical narrative: Pt reports L shoulder pain and L jaw pain that started 48 hours after COVID-19 Moderna booster injection. Patient received COVID-19 vaccine at another clinic. I evaluated patient on 02/13/2022 for L shoulder and L jaw pain.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Polymyalgia rheumatica
Clinical narrative: Polymyalsia Rhuematica
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site nodule, Pain
Clinical narrative: Patient developed an inflamed, dollar-sized knot at injection site the morning after the vaccination. She has pain shooting down arm when she moves it. She has tried applying ice at the affected area with no improvements.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: Sweating,  lightheadedness, dizziness within 5 minutes of administration.  Patient  requested medical attention and to lay down. Paramedics were requested and ,  upon arrival took care of patient.  Once stable and feeling better, patient went home by himself ( 40 min aprox after symptoms started)
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Arm soreness, large area of redness around site of injection painful and warm to the touch, swollen left armpit, fatigue for 2 days, headache, body aches
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: Arm soreness, large area of redness around site of injection painful and warm to the touch, swollen left armpit, fatigue for 2 days, headache, body aches
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy, Bronchiectasis, Computerised tomogram abdomen, Computerised tomogram thorax abnormal, Infection
Clinical narrative: Suspected metastatic disease of unknown origin, anticipate incurable course, doing very poorly in the hospital right now.  -CT chest, abd, pelvis: Multiple solid pulmonary nodules with the largest in the right upper lobe measuring up to 1.5 cm. These are suspicious for metastases. Loculated pleural fluid in the right major fissure. Additionally, there is adjacent bronchiectasis and streaky opacities of the right middle lobe and right lower lobe. The etiology for the fluid is not totally clear on this exam.  Metastatic disease versus infection seems most likely.  Lytic lesion in the right lateral ninth rib. Nodular soft tissue lesions of the right anterior chest wall and centered in the right gluteus musculature. Findings are most likely neoplastic or possibly infectious.